News
Investment
Research
Lifestyle
Search for:
Search
More
About us
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Biotech
LessDeath is planning for a post-aging future
Biotech
Juvenescence and Buck Institute launch company to target heart disease
Biotech
Preclinical study demonstrates long-term success of allogeneic islet implantation for diabetes
Co-implantation of allogeneic islets and streptavidin-presenting microgels provided excellent glycaemic control.
Biotech
Plug-and-play organ-on-a-chip can be customised patient-by-patient
Biotech
Startup boasts multiple novel compounds with potential to halt progress of age-related disease
Biotech
Genflow Biosciences moves into cellular reprogramming
Biotech
Small but mighty – how nanobodies are fighting chronic inflammation
Biotech
New lab grown miniature heart that can beat by itself
Biotech
YouthBio CEO: The time is right to develop epigenetic reprogramming therapies
Biotech
Strategic collaboration set to develop an iPSC-derived cell therapy platform
Biotech
Japan university tackles aging with transplanted pluripotent stem cells
Biotech
MitoRx Therapeutics lands funding to target mitochondrial dysfunction and age-related disease
Biotech
Juvenescence and Buck Institute set the (ke)tone for metabolism and ketosis research
Biotech
James Peyer: Geroscience evidence is the key to unlocking preventative therapies
Biotech
BioAge announces first cohort dosed in Phase 1b clinical trial of muscle aging therapy
Biotech
Active ingredient in Juvenescence’s Metabolic Switch induces ketosis, new study finds
Biotech
Low-dose lithium could slow kidney aging, new research finds
Biotech
YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth
Biotech
James Peyer on breaking the geroscience dam
Biotech
Andrew Steele: Our goal must be to cure aging
Biotech
We need a better understanding of senescence to build better senolytics
Biotech
SENISCA – targeted interventions that boast exquisite specificity
Biotech
Research reverses aging in human skin cells by 30 years
Biotech
Serpin therapy has fibrosis in its sights with clinical trial slated for 2023
Biotech
Swiss scientists crack muscle recovery, repairing age-related fatigue
Biotech
Fauna Bio partners with UW Oshkosh in search for novel therapies for disease
Biotech
Focus on frailty: New senolytic holds potential for sarcopenia treatment
Biotech
Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth
Biotech
Insilico identifies therapeutic targets implicated in aging using AI and hallmarks of aging framework
Biotech
Genflow collaborates with Aging Research Centre to drive sirtuin research
Biotech
Strategic partnership plans disruptive, personalised AI engine to counter skin aging
Biotech
Is gene therapy ready to take flight?
Biotech
Load More